Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedMay 21, 2026
DataAggregated Company Financials
Companies50
  • 7D4.7%
  • 3M5.8%
  • 1Y-7.3%
  • YTD-3.1%

The Medical Equipment industry is up 4.7% in the last week, with Implantica up 23%. In contrast, the industry has lost 7.3% in the last 12 months. Looking forward, earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 May 2026SEK 141.2bSEK 73.6bSEK 2.1b30.4x68.8x1.9x
Sat, 18 Apr 2026SEK 142.7bSEK 74.5bSEK 1.7b26.7x82.3x1.9x
Mon, 16 Mar 2026SEK 127.5bSEK 74.5bSEK 1.7b23.7x73.5x1.7x
Wed, 11 Feb 2026SEK 136.3bSEK 76.4bSEK 2.0b32x67.1x1.8x
Fri, 09 Jan 2026SEK 149.3bSEK 77.5bSEK 1.9b40.4x77.5x1.9x
Sun, 07 Dec 2025SEK 178.8bSEK 94.0bSEK 2.4b42.6x73.6x1.9x
Tue, 04 Nov 2025SEK 179.4bSEK 93.7bSEK 2.3b47.2x77.5x1.9x
Thu, 02 Oct 2025SEK 178.3bSEK 93.3bSEK 1.4b48x127.8x1.9x
Sat, 30 Aug 2025SEK 188.4bSEK 93.3bSEK 1.4b50.3x136.8x2x
Mon, 28 Jul 2025SEK 198.4bSEK 93.5bSEK 1.5b54.8x136.6x2.1x
Wed, 25 Jun 2025SEK 191.8bSEK 93.4bSEK 1.5b40.3x129.4x2.1x
Fri, 23 May 2025SEK 183.8bSEK 93.3bSEK 2.2b33.6x82.4x2x
Sun, 20 Apr 2025SEK 169.2bSEK 91.5bSEK 2.7b28.6x63.2x1.8x
Tue, 18 Mar 2025SEK 161.9bSEK 76.5bSEK 2.5b29x65x2.1x
Thu, 13 Feb 2025SEK 170.3bSEK 76.0bSEK 1.8b32.9x95.2x2.2x
Sat, 11 Jan 2025SEK 159.3bSEK 74.7bSEK 1.8b30.4x87.3x2.1x
Mon, 09 Dec 2024SEK 153.9bSEK 74.7bSEK 1.8b27.6x84.4x2.1x
Wed, 06 Nov 2024SEK 160.8bSEK 75.2bSEK 2.0b31.7x82.4x2.1x
Fri, 04 Oct 2024SEK 178.2bSEK 74.5bSEK 3.1b24.7x57.2x2.4x
Sun, 01 Sep 2024SEK 179.5bSEK 74.5bSEK 3.1b29.6x57.6x2.4x
Tue, 30 Jul 2024SEK 171.5bSEK 74.5bSEK 3.0b27.7x56.9x2.3x
Thu, 27 Jun 2024SEK 156.3bSEK 72.8bSEK 2.6b29.3x59.5x2.1x
Sat, 25 May 2024SEK 166.9bSEK 73.0bSEK 2.8b29.2x59.6x2.3x
Mon, 22 Apr 2024SEK 163.1bSEK 72.4bSEK 2.6b31.6x63.4x2.3x
Wed, 20 Mar 2024SEK 162.3bSEK 72.2bSEK 2.4b30.9x66.7x2.2x
Fri, 16 Feb 2024SEK 164.2bSEK 71.8bSEK 2.4b36.2x69.5x2.3x
Sun, 14 Jan 2024SEK 177.6bSEK 71.4bSEK 1.5b42.1x116.1x2.5x
Tue, 12 Dec 2023SEK 166.5bSEK 70.6bSEK 1.5b39.8x113.3x2.4x
Thu, 09 Nov 2023SEK 154.3bSEK 69.9bSEK 1.2b29.8x126x2.2x
Sat, 07 Oct 2023SEK 148.3bSEK 68.7bSEK 1.1b29.5x136.9x2.2x
Mon, 04 Sep 2023SEK 157.0bSEK 68.8bSEK 1.0b31x151.7x2.3x
Wed, 02 Aug 2023SEK 165.6bSEK 68.0bSEK 940.1m31.8x176.1x2.4x
Fri, 30 Jun 2023SEK 157.9bSEK 67.0bSEK 1.3b33.4x117.5x2.4x
Sun, 28 May 2023SEK 179.0bSEK 66.9bSEK 1.4b34.7x132.1x2.7x
Price to Earnings Ratio

132.1x


Total Market Cap: SEK 179.0bTotal Earnings: SEK 1.4bTotal Revenue: SEK 66.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 94.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 68.8x which is lower than its 3-year average PE of 94.1x.
  • The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 15% per year over the last three years.
  • Revenues for these companies have grown 3.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market2.00%
Healthcare3.00%
Medical Equipment4.73%
Medical Equipment5.79%
Medical Supplies0.34%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 78.6x.
    • Analysts are expecting annual earnings growth of 18.5%, which is higher than its past year's earnings decline of 17.5% per year.
  • Investors are most pessimistic about the Medical Supplies industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 35% over the next 5 years.
  • This is better than its past earnings growth rate of 22% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IMP A SDB ImplanticaSEK 57.6036.8%
+SEK 4.4b		54.8%PS723.7x
EKTA B ElektaSEK 60.307.1%
+SEK 1.5b		19.8%PS1.3x
GETI B GetingeSEK 196.502.6%
+SEK 1.4b		4.4%PE22.7x
XVIVO Xvivo PerfusionSEK 293.004.2%
+SEK 371.7m		-3.3%PE125x
SUS Surgical Science SwedenSEK 37.4215.0%
+SEK 249.0m		-73.8%PE36.6x

Latest News

IMP A SDB
SEK 57.60
Implantica
7D
36.8%
1Y
54.8%
SUS
SEK 37.42
Surgical Science Sweden
7D
15.0%
1Y
-73.8%
EKTA B
SEK 60.30
Elekta
7D
7.1%
1Y
19.8%
ARJO B
SEK 25.48
Arjo
7D
2.6%
1Y
-14.5%
CEVI
SEK 124.40
CellaVision
7D
3.3%
1Y
-34.4%
New Narrative • May 14

Digital Cell Analysis And New Applications Will Drive Long Term Upside Potential

Catalysts About CellaVision CellaVision develops digital microscopy solutions that help clinical laboratories automate and standardize blood and bone marrow cell analysis. What are the underlying business or industry changes driving this perspective?
CLS B
SEK 4.31
Clinical Laserthermia Systems
7D
-9.7%
1Y
59.1%
CMOTEC B
SEK 3.31
Scandinavian ChemoTech
7D
-8.8%
1Y
61.5%
XVIVO
SEK 293.00
Xvivo Perfusion
7D
4.2%
1Y
-3.3%
Narrative Update • May 10

XVIVO: Heart Trial Success Will Support Long Term Upside Potential

Analysts have revised their price target for Xvivo Perfusion from SEK 313.40 to SEK 337.00. This reflects updated assumptions on revenue growth, profit margins, discount rate and future P/E multiples.
GETI B
SEK 196.50
Getinge
7D
2.6%
1Y
4.4%
Narrative Update • May 08

GETI B: Higher Dividend And Profitability Assumptions Will Support Future Confidence

Analysts have maintained their SEK 270.0 price target for Getinge, with slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a more refined view of the stock's risk and earnings profile. What's in the News Getinge AB approved a dividend of SEK 4.75 per share at its Annual General Meeting held on April 21, 2026, following the proposal from the Board of Directors and the CEO (Key Developments).
NANEXA
SEK 3.61
Nanexa
7D
-2.6%
1Y
89.9%
VIMIAN
SEK 29.30
Vimian Group
7D
-2.8%
1Y
-26.8%
Narrative Update • May 06

VIMIAN: Margin Execution And Governance Changes Will Support Future Upside Potential

Analysts now see fair value for Vimian Group at about SEK 35, up from roughly SEK 34, even though the latest Street research includes a reduced price target to SEK 25 from SEK 27. This reflects updated views on revenue growth, margins, the appropriate discount rate and future P/E assumptions.
BACTI B
SEK 15.90
Bactiguard Holding
7D
-9.7%
1Y
-55.2%
EPIS B
SEK 0.14
Episurf Medical
7D
34.4%
1Y
22.4%
NOSA
SEK 0.57
Nosa Plugs
7D
-9.1%
1Y
-29.3%
VSD B
SEK 1.82
Vibrosense Dynamics
7D
-9.0%
1Y
108.7%
ORT B
SEK 8.50
Ortoma
7D
-2.2%
1Y
-36.8%